CIPOLLINI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 3.131
AS - Asia 1.382
EU - Europa 1.196
SA - Sud America 183
AF - Africa 52
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.959
Nazione #
US - Stati Uniti d'America 3.074
SG - Singapore 460
IT - Italia 439
CN - Cina 360
HK - Hong Kong 210
DE - Germania 193
BR - Brasile 159
VN - Vietnam 143
SE - Svezia 123
GB - Regno Unito 89
BG - Bulgaria 71
RU - Federazione Russa 56
FI - Finlandia 50
FR - Francia 46
CA - Canada 42
IN - India 42
TR - Turchia 39
KR - Corea 31
EE - Estonia 24
UA - Ucraina 21
CI - Costa d'Avorio 20
JP - Giappone 19
NL - Olanda 15
AR - Argentina 14
PL - Polonia 14
AU - Australia 13
BE - Belgio 13
BD - Bangladesh 11
IQ - Iraq 11
PK - Pakistan 9
SA - Arabia Saudita 9
AT - Austria 8
MA - Marocco 8
MX - Messico 8
CH - Svizzera 7
CZ - Repubblica Ceca 7
ES - Italia 7
ID - Indonesia 6
DZ - Algeria 5
PS - Palestinian Territory 5
SN - Senegal 5
JO - Giordania 4
LT - Lituania 4
UZ - Uzbekistan 4
DO - Repubblica Dominicana 3
EC - Ecuador 3
OM - Oman 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CR - Costa Rica 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
GA - Gabon 2
HN - Honduras 2
IE - Irlanda 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
PH - Filippine 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CM - Camerun 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
ML - Mali 1
MY - Malesia 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TG - Togo 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 5.959
Città #
Ashburn 347
Fairfield 288
Woodbridge 273
Dallas 243
Singapore 243
Ann Arbor 215
Houston 202
Hong Kong 198
San Jose 159
Chandler 156
Santa Clara 145
Seattle 136
Serra 135
Cambridge 116
Beijing 80
Wilmington 72
Sofia 70
Shanghai 66
Milan 63
New York 57
Boardman 50
Los Angeles 45
Ho Chi Minh City 39
Pisa 38
Princeton 36
Hefei 34
Munich 32
Council Bluffs 31
Ottawa 30
Lauterbourg 27
Medford 27
Frankfurt am Main 26
London 26
Lawrence 24
Hanoi 22
Seoul 22
Abidjan 20
Des Moines 20
Florence 19
Dong Ket 18
Tokyo 18
Genoa 17
Istanbul 16
Nanjing 14
Brussels 13
Helsinki 13
Buffalo 12
Columbus 12
Izmir 12
Lucca 12
Phoenix 12
Lancaster 11
Jacksonville 10
Lappeenranta 10
Livorno 10
Redondo Beach 10
San Diego 10
São Paulo 10
Warsaw 10
Dearborn 9
Nürnberg 9
Nettuno 8
Piombino 8
San Francisco 8
The Dalles 8
Turku 8
Fuzhou 7
Guangzhou 7
Nanchang 7
Rome 7
Viareggio 7
Bremen 6
Brooklyn 6
Casablanca 6
Daejeon 6
Pune 6
Shenyang 6
Vienna 6
Belo Horizonte 5
Bern 5
Chennai 5
Dakar 5
Islamabad 5
Las Vegas 5
Ogden 5
Orem 5
Redwood City 5
Rio de Janeiro 5
Stockholm 5
Washington 5
Amman 4
Ankara 4
Boulder 4
Bắc Ninh 4
Changsha 4
Düsseldorf 4
Falkenstein 4
Hyderabad 4
Jeddah 4
Naaldwijk 4
Totale 4.317
Nome #
Expression status of candidate genes in mesothelioma tissues and cell lines 341
Polymorphisms within base and nucleotide excision repair pathways and risk of differentiated thyroid carcinoma 312
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 307
Risk of Differentiated Thyroid Carcinoma and Polymorphisms within the Susceptibility Cancer Region 8q24 253
Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals 246
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 244
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma 241
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma 240
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 221
Inherited variants in genes somatically mutated in thyroid cancer 216
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma 211
Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology 208
Bona fide targets of deregulated microRNAs in non-small cell lung cancer as tool to identify novel therapeutic targets. A review. 203
Polymorphisms within the RET proto-oncogene and risk of sporadic medullary thyroid carcinoma 197
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations. 196
Genome-wide association study on differentiated thyroid cancer. 192
Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. 189
Evidences that the polymorphism Pro-282-Ala within the tumor suppressor gene WWOX is a new risk factor for differentiated thyroid carcinoma 186
Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk 181
The polymorphism rs2480258 within CYP2E1 is associated with different rates of acrylamide metabolism in vivo in humans 180
Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system 180
Correction: Inherited variants in genes somatically mutated in thyroid cancer 175
Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism 172
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma 163
Runs of homozygosity and inbreeding in thyroid cancer 149
High prevalence of chromosome 10 rearrangements in human lymphocytes after in vitro X-ray irradiation 148
Polymorphism Pro64His within galectin-3 has functional consequences at proteome level in thyroid cells 142
MicroRNA binding site polymorphisms as biomarkers in cancer management and research. 136
Variation rs2235503 C > A Within the Promoter of MSLN Affects Transcriptional Rate of Mesothelin and Plasmatic Levels of the Soluble Mesothelin-Related Peptide 131
Functional polymorphism within NUP210 encoding for nucleoporin GP210 is associated with the risk of endometriosis 128
null 17
Totale 6.105
Categoria #
all - tutte 15.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.899


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 0 0 0 0 0 0 0 26 78
2021/2022354 14 37 12 15 64 44 14 18 17 10 17 92
2022/2023472 44 78 29 43 42 66 3 43 77 3 41 3
2023/2024371 55 30 74 16 33 59 12 18 2 15 26 31
2024/20251.222 2 38 15 97 120 119 129 63 103 156 136 244
2025/20261.534 138 194 198 104 145 130 332 83 95 110 5 0
Totale 6.105